Quantcast
Tag archive for ‘drugs and supplements’
By The Dispatch On Thursday, November 5th, 2015
0 Comments

HIV treatment, Genvoya, gets FDA nod

The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment More...

By The Dispatch On Monday, January 26th, 2015
0 Comments

Generic version of Nexium approved to treat GERD

The U.S. Food and Drug Administration today approved the first generic version of Nexium (esomeprazole magnesium delayed-release capsules) to treat gastroesophageal reflux disease (GERD) in adults and children ages More...

By The Dispatch On Wednesday, January 21st, 2015
0 Comments

New warnings issued for Alzheimer’s drug, Aricept: Health Canada

New warnings have been added to the prescribing information for the Alzheimer’s drug Aricept (donepezil) advising of the risk of two rare but potentially serious conditions: muscle breakdown (rhabdomyolysis) and More...

By The Dispatch On Wednesday, January 21st, 2015
2 Comments

Novartis psoriasis drug, Cosentyx, receives FDA approval

The U.S. Food and Drug Administration today approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis. PsoriasisPublic domain image/Bodiadub Psoriasis is a skin condition that causes More...

By The Dispatch On Friday, January 9th, 2015
2 Comments

Blood clot prevention drug, Savaysa, gets FDA approval

The U.S. Food and Drug Administration today approved the anti-clotting drug Savaysa (edoxaban tablets) to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation More...

By The Dispatch On Tuesday, December 23rd, 2014
2 Comments

Novo Nordisk’s Saxenda receives FDA approval for chronic weight management treatment

The U.S. Food and Drug Administration today approved Saxenda (liraglutide [rDNA origin] injection) as a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. The More...

By The Dispatch On Monday, December 22nd, 2014
0 Comments

Melanoma drug, Opdivo, gets FDA approval

The U.S. Food and Drug Administration today granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with unresectable (cannot be removed by surgery) or metastatic (advanced) melanoma who More...

By The Dispatch On Friday, December 19th, 2014
0 Comments

Ovarian cancer drug, Lynparza, receives FDA approval

The U.S. Food and Drug Administration today granted accelerated approval to Lynparza (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes, as detected by an More...

By Robert On Tuesday, December 16th, 2014
0 Comments

FDA warns of dangers of powdered pure caffeine

The US Food and Drug Administration (FDA) is advising the public about powdered pure caffeine that is sold on the internet and recommends people avoid these products. In an FDA Blog today, Director of FDA’s More...

By The Dispatch On Sunday, October 26th, 2014
0 Comments

FDA approves Obizur for treating hemophilia A bleeding episodes in adults

The U.S. Food and Drug Administration approved Obizur [Antihemophilic Factor (Recombinant), Porcine Sequence] for the treatment of bleeding episodes in adults with acquired hemophilia A (acquired Factor VIII [FVII] More...

By The Dispatch On Wednesday, August 13th, 2014
0 Comments

Sleep drug, Belsomra, gets FDA nod

The U.S. Food and Drug Administration today approved Belsomra (suvorexant) tablets for use as needed to treat difficulty in falling and staying asleep (insomnia). Belsomra is an orexin receptor antagonist and is More...

By The Dispatch On Friday, August 1st, 2014
2 Comments

Type 2 diabetes drug, Jardiance, receives FDA approval

The U.S. Food and Drug Administration today approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to improve glycemic control in adults with type 2 diabetes. Diabetes symptomsPublic domain More...

By The Dispatch On Thursday, July 31st, 2014
1 Comment

Chikungunya and dengue fever anti-viral invented by Florida researcher

The Vaccine & Gene Therapy Institute of Florida (VGTI Florida®), a leading non-profit biomedical research institute, today announced a key milestone achievement in developing novel approaches for the prevention More...

By The Dispatch On Thursday, July 31st, 2014
0 Comments

COPD drug, Striverdi Respimat, receives FDA approval

Today, the U.S. Food and Drug Administration approved Striverdi Respimat (olodaterol) inhalation spray to treat patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema More...

By The Dispatch On Monday, July 28th, 2014
0 Comments

CLL drug, Imbruvica, receives FDA approval for expanded use

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which More...

By The Dispatch On Thursday, July 24th, 2014
0 Comments

Merck announces start of Phase III study of CMV drug, Letermovir

Merck announced today that the first patient has been enrolled in a global Phase 3 clinical study of letermovir (MK-8228), an investigational antiviral agent. The multicenter, randomized, placebo-controlled study More...

By The Dispatch On Wednesday, July 23rd, 2014
2 Comments

FDA approves Targiniq ER, extended-release oxycodone, to treat severe pain

Today, the U.S. Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), an extended-release/long-acting (ER/LA) opioid analgesic to treat More...

By The Dispatch On Wednesday, July 23rd, 2014
1 Comment

Gilead Sciences cancer drug, Zydelig, receives FDA approval

The U.S. Food and Drug Administration today approved Zydelig (idelalisib) to treat patients with three types of blood cancers. Zydelig is being granted traditional approval to treat patients whose chronic lymphocytic More...

By The Dispatch On Thursday, July 17th, 2014
0 Comments

FDA approves Ruconest for the treatment of acute attacks in patients with hereditary angioedema

The U.S. Food and Drug Administration yesterday approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema More...

By The Dispatch On Wednesday, July 16th, 2014
0 Comments

Senators question Gilead Sciences CEO about pricey Hepatitis C drug, Sovaldi

Senate Finance Committee Chairman Ron Wyden, D-Ore., and senior Finance Committee member Chuck Grassley, R-Iowa, Friday requested detailed pricing information on a costly new Hepatitis C virus (HCV) drug. Wyden More...

like_us_on_facebook

 

The Global Dispatch Facebook page- click here

Movie News Facebook page - click here

Television News Facebook page - click here

Weird News Facebook page - click here 

DISPATCH RADIO

dispatch_radio

THE BRANDON JONES SHOW

brandon_jones_show-logo

Categories